文献速递妇科生殖医学

直肠子宫内膜异位症手术治疗后的长期结局:随机试验入组患者的七年随访

Long-term Outcomes Following Surgical Management of Rectal Endometriosis: Seven-year Follow-up of Patients Enrolled in a Randomized Trial.
PubMed 文献 · J Minim Invasive Gynecol · 2022-02-16

本研究对55例深部直肠子宫内膜异位症患者进行为期7年的前瞻性随访,比较保守手术与根治性手术的功能结局、复发率与妊娠可能性。结果显示两组的消化道功能症状、复发率、再手术风险及妊娠率均无显著差异,术后妊娠率较高。

要点

  • 7年随访时,保守组与根治组的复发率分别为7.4%与0%(p=.24),差异无统计学意义。
  • 两组分别有55.6%与60.7%的患者记录到主要结局定义中的任一症状(p=.79)。
  • 尝试妊娠的37例患者中31例成功(83.8%),活产率为75.7%,两组妊娠率无显著差异。

核心结论

  • 研究未发现保守与根治性直肠手术治疗深部子宫内膜异位症在7年后的消化道功能结局、复发率、再手术风险及妊娠可能性方面存在显著差异。
  • 本系列中观察到的术后妊娠率较高。

研究设计与样本

  • 前瞻性研究,队列来自2011年3月至2013年8月入组的两臂随机试验。
  • 共纳入55例深部子宫内膜异位症浸润直肠的患者。
  • 干预为节段性切除或通过剃除或盘状切除的结节切除,术前使用顺序编号的不透明密封信封进行随机分组。
  • 主要终点为术后24个月出现便秘、排便频繁、肛门失禁或膀胱功能障碍之一的患者数。

主要发现

  • 7年复发率(新发深部子宫内膜异位症结节浸润直肠)在切除组与节段切除组分别为7.4%与0%(p=.24)。
  • 主要结局定义中的任一症状在两组分别记录于55.6%与60.7%的患者(p=.79)。
  • 分别有51.9%与53.6%的患者认为自己的排便正常(p=.99)。
  • 意向性治疗比较显示两组术后7年总体生活质量评分无差异。
  • 7年末,37例尝试妊娠的患者中31例成功(83.8%),其中自然受孕27例(57.4%),辅助生殖技术助孕20例(42.6%);两臂妊娠率分别为82.4%与85%(p=.99),活产率为75.7%;随访结束时15例女性有1个孩子(40.5%),13例有2个孩子(35.1%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To compare functional outcomes, recurrence rate, and pregnancy likelihood in patients undergoing conservative or radical surgery for deep rectal endometriosis followed up for 7 years. DESIGN: Prospective study in a cohort of patients enrolled in a 2-arm randomized trial from March 2011 to August 2013. SETTING: A tertiary referral center. PATIENTS: Fifty-five patients with deep endometriosis infiltrating the rectum. INTERVENTIONS: Patients underwent either segmental resection or nodule excision via shaving or disk excision, depending on randomization that was performed preoperatively using sequentially numbered, opaque sealed envelopes. MEASUREMENTS AND MAIN RESULTS: The primary end point was the number of patients experiencing one of the following symptoms: constipation, frequent bowel movements, anal incontinence, or bladder dysfunction 24 months after surgery. The secondary end points were values of gastrointestinal and overall quality of life scores. The 7-year recurrence rates (new deep endometriosis nodules infiltrating the rectum) in the excision vs segmental resection arms were 7.4 % vs 0% (p = .24). One of the symptoms included in the definition of the primary outcomes was recorded in 55.6% vs 60.7% of patients (p = .79). However, 51.9% vs 53.6% of patients considered their bowel movements as normal (p = .99). An intention-to-treat comparison of overall quality of life scores did not find a difference between the 2 groups 7 years after surgery. At the end of the 7-year study period, 31 of 37 patients who tried to conceive were successful (83.8%), including 27 pregnancies (57.4%) resulting from natural conception and 20 pregnancies (42.6%) resulting from assisted reproductive technology procedures. The pregnancy rate was 82.4% vs 85% in the 2 arms (p = .99). A 75.7% live birth rate was recorded. At the end of the follow-up, there were 15 women with 1 child (40.5%) and 13 women with 2 children (35.1%). During the 7-year follow-up, the reoperation rates were 37% and 35.7%, respectively, in each arm (p = .84). Among the 27 reoperation procedures during the follow-up period, 11 (40.7%) were for postoperative complications, 7 (25.9%) were necessary before assisted reproductive technology management, 8 (29.6%) were for recurrent abdominal or pelvic pain, and 1 (3.7%) was for midline ventral hernia after pregnancy. CONCLUSION: Our study did not reveal a considerable difference in terms of digestive functional outcomes, recurrence rate, reoperation risk, and pregnancy likelihood when conservative and radical rectal surgeries for deep endometriosis were compared 7 years after surgery. The postoperative pregnancy rate observed in our series was high.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Roman H, Huet E, Bridoux V, et al. Long-term Outcomes Following Surgical Management of Rectal Endometriosis: Seven-year Follow-up of Patients Enrolled in a Randomized Trial. J Minim Invasive Gynecol. 2022. PMID: 35181523. doi:10.1016/j.jmig.2022.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。